Marksans Pharma fell 4.35% to Rs 62.65 at 10:44 IST on BSE as fresh shares allotted by the company to institutional investors recently were admitted for trading on the bourses today, 7 April 2015.
Meanwhile, the BSE Sensex was up 21.48 points, or 0.08%, to 28,525.94.
On BSE, so far 2.73 lakh shares were traded in the counter, compared with an average volume of 7.56 lakh shares in the past one quarter.
The stock hit a high of Rs 66 and a low of Rs 62.70 so far during the day. The stock hit a record high of Rs 72 on 5 January 2015. The stock hit a 52-week low of Rs 20.10 on 4 June 2014.
The stock had outperformed the market over the past one month till 6 April 2015, rising 7.82% compared with 3.21% decline in the Sensex. The scrip had, however, underperformed the market in past one quarter, rising 0.85% as against Sensex's 5.62% rise.
The small-cap company has an equity capital of Rs 40.93 crore. Face value per share is Re 1.
More From This Section
Shares allotted by Marksans Pharma to institutional investors under Qualified Institutional Placement (QIP) were admitted for trading on the bourses today, 7 April 2015. A total of 2.40 crore shares of the company were admitted for trading. Marksans Pharma had priced the issue of shares to institutional investors at Rs 54.67 per share.
Late last month, Marksans Pharma raised Rs 131.24 crore from the QIP issue.
On a consolidated basis, net profit of Marksans Pharma rose 23.31% to Rs 27.72 crore on 26.39% rise in net sales to Rs 213.29 crore in Q3 December 2014 over Q3 December 2013.
Marksans Pharma is engaged in research, manufacturing and marketing of generic pharmaceutical formulation in the global market.
Powered by Capital Market - Live News